BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38043360)

  • 21. Long-term trends in gender, T-stage, subsite and treatment for laryngeal cancer at a single center.
    Brandstorp-Boesen J; Falk RS; Boysen M; Brøndbo K
    Eur Arch Otorhinolaryngol; 2014 Dec; 271(12):3233-9. PubMed ID: 24871863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between pathological differentiation and survival outcomes of patients with laryngeal squamous cell carcinoma.
    Zhu Y; Shi X; Zhu X; Diao W; Chen X
    Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4595-4604. PubMed ID: 35581439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
    Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
    Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analysis of 659 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations.
    Tang D; Tao L; Zhou L; Zhang M; Wu H; Li X; Chen X; Li C; Xie M; Cheng L
    Acta Otolaryngol; 2018 Nov; 138(11):1043-1050. PubMed ID: 30776268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas.
    Wachters JE; Kop E; Slagter-Menkema L; Mastik M; van der Wal JE; van der Vegt B; de Bock GH; van der Laan BFAM; Schuuring E
    Laryngoscope; 2020 Dec; 130(12):2825-2832. PubMed ID: 32065407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Aberrant expression of CyclinE and p27 in laryngeal squamous cell carcinoma and the clinical significance].
    Chai D; Bao Z; Hu J; Ma L; Feng Z; Tao Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(3):165-9, 174. PubMed ID: 24826452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB).
    Shikama N; Sasaki S; Nishikawa A; Koiwai K; Yoshino F; Hirase Y; Kawakami R; Kadoya M; Oguchi M
    Radiology; 2003 Sep; 228(3):789-94. PubMed ID: 12954897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
    Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
    Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of vasculogenic mimicry and endothelium-dependent vessel in metastasis of laryngeal cancer].
    Wang W; Lin P; Sun BC; Cai WJ; Han CR; Li L; Lu HH; Zhang JM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 May; 47(5):400-5. PubMed ID: 22883583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma.
    Vivatvakin S; Ratchataswan T; Leesutipornchai T; Ruangritchankul K; Keelawat S; Mahattanasakul P; Bongsebandhu-Phubhakdi S
    Sci Rep; 2021 Jul; 11(1):14607. PubMed ID: 34272446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retrospective analysis of 760 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations].
    Tao L; Zhou L; Wu HT; Li XM; Chen XL; Li C; Xie M; Zhang M; Cheng L; Tang D
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(10):737-744. PubMed ID: 29873209
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness of routine follow-up of patients treated for T1-2N0 oral squamous cell carcinomas of the floor of mouth and tongue.
    Merkx MA; van Gulick JJ; Marres HA; Kaanders JH; Bruaset I; Verbeek A; de Wilde PC
    Head Neck; 2006 Jan; 28(1):1-7. PubMed ID: 16155911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follow-up after curative treatment for oral squamous cell carcinoma. A critical appraisal of the guidelines and a review of the literature.
    Brands MT; Brennan PA; Verbeek ALM; Merkx MAW; Geurts SME
    Eur J Surg Oncol; 2018 May; 44(5):559-565. PubMed ID: 29433990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical value of serum HMGB1 in diagnosis and prognosis of laryngeal squamous cell carcinoma.
    Qiu G; Li Y; Liu Z; Wang M; Ge J; Bai X
    Med Oncol; 2014 Dec; 31(12):316. PubMed ID: 25373322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Intensive 18F-Fludeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Strategy of Follow-Up in Patients Treated for Head and Neck Squamous Cell Carcinoma Who Are Clinically Asymptomatic.
    Leclère JC; Clément C; Le Pennec R; Maheo C; Gujral DM; Schick U; Le Gal G; Marianowski R; Salaun PY; Abgral R
    JAMA Netw Open; 2023 Aug; 6(8):e2326654. PubMed ID: 37526935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the Larynx.
    Gainor DL; Marchiano E; Bellile E; Spector ME; Taylor JMG; Wolf GT; Hogikyan ND; Prince ME; Bradford CR; Eisbruch A; Worden F; Shuman AG
    Otolaryngol Head Neck Surg; 2017 Oct; 157(4):625-630. PubMed ID: 28608731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic-assisted selective neck dissection via small lateral neck incision for early-stage (T1-2N0M0) head and neck squamous cell carcinoma: 3-year follow-up results.
    Liang F; Fan S; Han P; Cai Q; Lin P; Chen R; Yu S; Huang X
    Surg Endosc; 2017 Feb; 31(2):894-900. PubMed ID: 27369288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Critical Reappraisal of Primary and Recurrent Advanced Laryngeal Cancer Staging.
    Locatello LG; Pietragalla M; Taverna C; Bonasera L; Massi D; Mannelli G
    Ann Otol Rhinol Laryngol; 2019 Jan; 128(1):36-43. PubMed ID: 30360641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
    Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D
    Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.